Catalyst Wire Dossier Catalyst Wire Dossier

PD-1 antibody expressing mesoCAR-T cells

PD-1 antibody expressing mesoCAR-T cells · Shanghai Cell Therapy Research Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PD-1 antibody expressing mesoCAR-T cells, covering 2018-08-03 to 2018-08-03. Get the full timeline:

Most recent: Clinical Trial Update: PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor [Phase 1, Phase 2]

See pricing